Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Vanda Pharmaceuticals (VNDA)

Vanda Pharmaceuticals (VNDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 318,533
  • Shares Outstanding, K 59,097
  • Annual Sales, $ 198,770 K
  • Annual Income, $ -18,900 K
  • EBIT $ -114 M
  • EBITDA $ -113 M
  • 60-Month Beta 0.69
  • Price/Sales 1.55
  • Price/Cash Flow N/A
  • Price/Book 0.66

Options Overview Details

View History
  • Implied Volatility 169.41% (+73.33%)
  • Historical Volatility 104.43%
  • IV Percentile 95%
  • IV Rank 46.48%
  • IV High 332.52% on 11/14/25
  • IV Low 27.75% on 09/04/25
  • Expected Move (DTE 11) 0.68 (11.07%)
  • Put/Call Vol Ratio 0.03
  • Today's Volume 4,124
  • Volume Avg (30-Day) 1,630
  • Put/Call OI Ratio 0.13
  • Today's Open Interest 28,040
  • Open Int (30-Day) 24,405
  • Expected Range 5.46 to 6.82

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -1.45
  • Number of Estimates 2
  • High Estimate -0.74
  • Low Estimate -2.16
  • Prior Year -0.08
  • Growth Rate Est. (year over year) -1,712.50%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.28 +43.46%
on 11/14/25
6.32 -2.85%
on 12/08/25
+1.74 (+39.55%)
since 11/07/25
3-Month
4.27 +43.79%
on 11/07/25
6.32 -2.85%
on 12/08/25
+1.59 (+34.95%)
since 09/08/25
52-Week
3.81 +61.19%
on 05/15/25
6.32 -2.85%
on 12/08/25
+1.30 (+26.86%)
since 12/06/24

Most Recent Stories

More News
FDA Lifts Partial Clinical Hold on Tradipitant for Motion Sickness

WASHINGTON , Dec. 4, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) today announced that the U.S. Food and Drug Administration (FDA) has lifted the partial clinical hold on protocol...

VNDA : 6.14 (+13.91%)
Vanda Pharmaceuticals Provides Regulatory Update on Tradipitant for Motion Sickness

WASHINGTON , Nov. 28, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA), today announced the following updates regarding tradipitant for motion sickness:

VNDA : 6.14 (+13.91%)
Vanda Pharmaceuticals Reports Positive Results for Tradipitant in Preventing GLP-1 Induced Nausea and Vomiting

Vanda's Tradipitant Study Success Positions it as Key Adjunct in $50B+ Global GLP-1 Agonist Market

VNDA : 6.14 (+13.91%)
Vanda Pharmaceuticals Announces Participation in the Stifel 2025 Healthcare Conference

WASHINGTON , Nov. 5, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA ) today announced that the company will participate in the Stifel 2025 Healthcare Conference in New...

VNDA : 6.14 (+13.91%)
Vanda: Q3 Earnings Snapshot

Vanda: Q3 Earnings Snapshot

VNDA : 6.14 (+13.91%)
Vanda Pharmaceuticals Reports Third Quarter 2025 Financial Results

WASHINGTON , Oct. 29, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced financial and operational results for the third quarter ended September 30, 2025.

VNDA : 6.14 (+13.91%)
Vanda Pharmaceuticals to Announce Third Quarter 2025 Financial Results on October 29, 2025

Conference Call and Webcast to Follow

VNDA : 6.14 (+13.91%)
Monumental Sports & Entertainment Taps D.C.'s Own Vanda Pharmaceuticals as Founding Partner to Help Drive the Creation of Brand-New Downtown Arena

Multiyear agreement includes exclusive Monumental Sports Network studio entitlement, activations across Capitals, Wizards, and Mystics, and deep integration via community and media platforms

VNDA : 6.14 (+13.91%)
Vanda Pharmaceuticals Reaches Agreement with FDA

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Vanda ( (VNDA)...

VNDA : 6.14 (+13.91%)
Vanda Pharmaceuticals Announces Collaborative Framework for Resolution of Disputes with the U.S. Food and Drug Administration

WASHINGTON , Oct. 1, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that it has agreed on a collaborative framework with the U.S. Food and Drug...

VNDA : 6.14 (+13.91%)

Business Summary

Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of clinical-stage product candidates for central nervous system disorders. It is developing important new medicines to improve the lives of patients. It uses new technologies, including genetics...

See More

Key Turning Points

3rd Resistance Point 7.40
2nd Resistance Point 6.86
1st Resistance Point 6.50
Last Price 6.14
1st Support Level 5.60
2nd Support Level 5.06
3rd Support Level 4.70

See More

52-Week High 6.32
Last Price 6.14
Fibonacci 61.8% 5.36
Fibonacci 50% 5.06
Fibonacci 38.2% 4.77
52-Week Low 3.81

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar